Chemokines in liver inflammation and fibrosis.
暂无分享,去创建一个
[1] K. Matsushima,et al. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. , 1999, The Journal of clinical investigation.
[2] K. Ley,et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[4] H. Bonkovsky,et al. Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. , 1998, Hepatology.
[5] R. Bronson,et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. J. Valente,et al. Identification of monocyte chemotactic activity produced by malignant cells. , 1989, Science.
[7] N. Kaplowitz,et al. Oxidative stress and liver disease. , 1996, Progress in liver diseases.
[8] R. Strieter,et al. Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1. , 2000, The American journal of pathology.
[9] A. Lentsch,et al. Mechanisms of hypothermic protection against ischemic liver injury in mice. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[10] G. Reynolds,et al. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. , 2002, The American journal of pathology.
[11] K. Khabar,et al. Elevated Levels of Interleukin-8 in Serum Are Associated with Hepatitis C Virus Infection and Resistance to Interferon Therapy , 2001, Journal of Virology.
[12] N. Sheron,et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin‐8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration , 1993, Hepatology.
[13] C. McClain,et al. Increased plasma interleukin‐8 concentrations in alcoholic hepatitis , 1993, Hepatology.
[14] C. Chan,et al. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. , 1996, Journal of hepatology.
[15] Edwards,et al. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein‐2 and KC , 1998, Hepatology.
[16] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[17] J. Teruya-Feldstein,et al. Contribution of the CXC chemokines IP‐10 and Mig to the antitumor effects of IL‐12 , 1998, Journal of leukocyte biology.
[18] S. Shaw,et al. Stimulation of monocyte interleukin-8 by lipid peroxidation products: a mechanism for alcohol-induced liver injury. , 1998, Alcohol.
[19] M. Burdick,et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. , 1995, The Journal of clinical investigation.
[20] Shou-Dong Lee,et al. Plasma interleukin‐8 levels in patients with post‐hepatitic cirrhosis: Relationship to severity of liver disease, portal hypertension and hyperdynamic circulation , 1996, Journal of gastroenterology and hepatology.
[21] C. Degott,et al. Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. , 2001, Journal of hepatology.
[22] J. Maher,et al. Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[23] M. Burdick,et al. PROLIFERATIVE EFFECTS OF CXC CHEMOKINES IN RAT HEPATOCYTES IN VITRO AND IN VIVO , 1998, Shock.
[24] R. Strieter,et al. Novel CXCR2‐dependent liver regenerative qualities of ELR‐containing CXC chemokines , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] A. Foussat,et al. Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Standiford,et al. MCP-1 protects mice in lethal endotoxemia. , 1997, The Journal of clinical investigation.
[27] C. McClain,et al. Increased monocyte MCP-1 production in acute alcoholic hepatitis. , 1999, Cytokine.
[28] K. Matsushima,et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.
[29] Y. Yamaguchi,et al. Neutrophil elastase and oxygen radicals enhance monocyte chemoattractant protein- expression after ischemia/reperfusion in rat liver. , 1999, Transplantation.
[30] D. Adams,et al. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1α in alcoholic liver disease , 1999, Gut.
[31] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.
[32] K. S. Lee,et al. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. , 1995, The Journal of clinical investigation.
[33] G. Bishop,et al. Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. , 1994, Gastroenterology.
[34] A. J. Valente,et al. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. , 1993, The Journal of clinical investigation.
[35] R. Strieter,et al. Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. , 2000, Experimental and molecular pathology.
[36] A. Lentsch,et al. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. , 1999, The Journal of surgical research.
[37] L. Colletti,et al. Lung and liver injury following hepatic ischemia/reperfusion in the rat is increased by exogenous lipopolysaccharide which also increases hepatic TNF production in vivo and in vitro. , 2001, Shock.
[38] F. Marra,et al. Monocyte chemotactic protein‐1 as a chemoattractant for human hepatic stellate cells , 1999, Hepatology.
[39] S. Milani,et al. Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[40] Y. Yamaguchi,et al. Enhanced expression of cytokine‐induced neutrophil chemoattractant in rat hepatic allografts during acute rejection , 1997, Hepatology.
[41] D. Adams,et al. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis , 1998, The Journal of pathology.
[42] M. Miyazaki,et al. IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. , 1999, The American journal of pathology.
[43] A. Watanabe,et al. CC‐chemokine receptor 6 and its ligand macrophage inflammatory protein 3α might be involved in the amplification of local necroinflammatory response in the liver , 2001, Hepatology.
[44] K. Kohno,et al. Alcoholic fatty liver differentially induces a neutrophil‐chemokine and hepatic necrosis after ischemia‐reperfusion in rat , 2000, Hepatology.
[45] R. Caporale,et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. , 2000, Gastroenterology.
[46] J. Ross,et al. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. , 1997, American journal of physiology. Endocrinology and metabolism.
[47] P. Murphy. Viral exploitation and subversion of the immune system through chemokine mimicry , 2001, Nature Immunology.
[48] S. Narula,et al. Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. , 1999, Journal of immunology.
[49] R. Strieter,et al. IFN-γ-Inducible Protein-10 (CXCL10) Is Hepatoprotective During Acute Liver Injury Through the Induction of CXCR2 on Hepatocytes1 , 2001, The Journal of Immunology.
[50] Hiroshi Matsumoto,et al. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat , 1999, Hepatology.
[51] M. Burdick,et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. , 1996, Hepatology.
[52] S. Milani,et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. , 1998, The American journal of pathology.
[53] A. Lentsch,et al. Interleukin‐10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κB , 1999, Hepatology.
[54] G. Barber,et al. Hepatitis C Virus Nonstructural 5A Protein Induces Interleukin-8, Leading to Partial Inhibition of the Interferon-Induced Antiviral Response , 2001, Journal of Virology.
[55] C. Mackay,et al. Chemokines: immunology's high impact factors , 2001, Nature Immunology.
[56] K. Matsushima,et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. , 1998, The Journal of clinical investigation.
[57] G. Karupiah,et al. Transcription of the interferon gamma (IFN-gamma )-inducible chemokine Mig in IFN-gamma-deficient mice. , 2001, The Journal of biological chemistry.
[58] M. Czaja,et al. Monocyte chemoattractant protein 1 (MCP‐1) expression occurs in toxic rat liver injury and human liver disease , 1994, Journal of leukocyte biology.
[59] F. Marra. Hepatic stellate cells and the regulation of liver inflammation. , 1999, Journal of hepatology.
[60] R. Strieter,et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.
[61] K. Kharbanda,et al. Brief communication Malondialdehyde-acetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells , 2001 .
[62] D. Adams,et al. Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation. , 1996, Transplantation.
[63] C. Mackay,et al. Monocyte chemotactic protein‐1, ‐2, and ‐3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis , 2001, The Journal of pathology.
[64] Ping Zhang,et al. ATTENUATION OF HEPATIC NEUTROPHIL SEQUESTRATION BY ANTI‐CINC ANTIBODY IN ENDOTOXIC RATS , 1995, Shock.
[65] J. Maher. Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol. , 1995, The American journal of physiology.
[66] J. Wigginton,et al. Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2). , 2001, Journal of immunology.
[67] Y. Tominaga,et al. Expression of IFN-inducible protein-10 in chronic hepatitis. , 1997, Journal of immunology.
[68] N. Horiike,et al. Increased serum levels of macrophage inflammatory protein‐3α in chronic viral hepatitis: prognostic importance of macrophage inflammatory protein‐3α during interferon therapy in chronic hepatitis C , 2002, Journal of viral hepatitis.
[69] J. Maher,et al. Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. , 1998, The American journal of physiology.
[70] S. Milani,et al. Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. , 2002, Journal of hepatology.
[71] M. Mori,et al. Reduced expression of the CXC chemokine hIRH/SDF‐1α mRNA in hepatoma and digestive tract cancer , 1997, International journal of cancer.
[72] B. Rollins,et al. Chemokines and disease , 2001, Nature Immunology.
[73] M. Czaja,et al. Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. , 1996, Gastroenterology.
[74] R. Schwabe,et al. CD40 Activates NF-κB and c-Jun N-Terminal Kinase and Enhances Chemokine Secretion on Activated Human Hepatic Stellate Cells1 , 2001, The Journal of Immunology.
[75] A. J. Valente,et al. Agonist‐specific regulation of monocyte chemoattractant protein‐1 expression by cyclooxygenase metabolites in hepatic stellate cells , 2001, Hepatology.
[76] D. Brenner,et al. Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. , 1998, The American journal of physiology.
[77] J. Cyster,et al. Chemokines as regulators of T cell differentiation , 2001, Nature Immunology.
[78] S. Kunkel,et al. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. , 2000, The American journal of pathology.
[79] G. Su,et al. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[80] J. Kolls,et al. Acute alcohol intoxication suppresses the CXC chemokine response during endotoxemia. , 2002, Alcoholism, clinical and experimental research.
[81] G. McCaughan,et al. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection , 2000, Gut.
[82] M. Serio,et al. Signal Transduction by the Chemokine Receptor CXCR3 , 2001, The Journal of Biological Chemistry.
[83] J. Kuratsu,et al. Monocyte chemoattractant protein‐1 enhances expression of intercellular adhesion molecule‐1 following ischemia‐reperfusion of the liver in rats , 1998, Hepatology.
[84] A. Lentsch,et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). , 2000, Blood.
[85] G. Gerken,et al. Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity , 1995, Hepatology.
[86] V. Carloni,et al. Integrin‐mediated stimulation of monocyte chemotactic protein‐1 expression , 1997, FEBS letters.
[87] K. Matsushima,et al. Regulation by Chemokines of Circulating Dendritic Cell Precursors, and the Formation of Portal Tract–Associated Lymphoid Tissue, in a Granulomatous Liver Disease , 2001, The Journal of experimental medicine.
[88] N. Habib,et al. Hepatic ischemia-reperfusion injury. , 2001, American journal of surgery.
[89] M. Abe,et al. Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis. , 1998, Hepato-gastroenterology.
[90] D. Adams,et al. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. , 1999, Journal of immunology.
[91] G. Karupiah,et al. The Interferon-Inducible Chemokines MuMig and Crg-2 Exhibit Antiviral Activity In Vivo , 1999, Journal of Virology.
[92] D. Adams,et al. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. , 1997, Proceedings of the Association of American Physicians.
[93] G. Ramadori,et al. Enhanced Expression of Interferon-Regulated Genes in the Liver of Patients with Chronic Hepatitis C Virus Infection: Detection by Suppression-Subtractive Hybridization , 2001, Journal of Virology.
[94] J. Iredale,et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.
[95] A. Farhood,et al. Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[96] D. Adams,et al. Expression and function of CXC and CC chemokines in human malignant liver tumors: A role for human monokine induced by γ‐interferon in lymphocyte recruitment to hepatocellular carcinoma , 1999, Hepatology.
[97] Y. Shiratori,et al. Production of chemotactic factor, interleukin‐8, from hepatocytes exposed to ethanol , 1993, Hepatology.
[98] L. Toledo-Pereyra,et al. L-Selectin and chemokine response after liver ischemia and reperfusion. , 2000, The Journal of surgical research.
[99] J. Cyster,et al. Chemokines and cell migration in secondary lymphoid organs. , 1999, Science.
[100] W. Alvord,et al. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus. , 1998, Journal of immunology.
[101] K. Mimori,et al. Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2. , 2001, Cellular signalling.
[102] S. Friedman. Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.
[103] J. Maher,et al. Adenovirus‐mediated expression of cytokine‐induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis , 1997, Hepatology.
[104] L. Koniaris,et al. Cytokine-Responsive Gene-2/IFN-Inducible Protein-10 Expression in Multiple Models of Liver and Bile Duct Injury Suggests a Role in Tissue Regeneration1 , 2001, The Journal of Immunology.
[105] K. Matsushima,et al. Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. , 2000, Cytokine.
[106] F. Marumo,et al. Expression of C-C Chemokines is Associated with Portal and Periportal Inflammation in the Liver of Patients with Chronic Hepatitis C , 2000, Laboratory Investigation.
[107] M. Burdick,et al. The ratio of ELR+ to ELR− CXC chemokines affects the lung and liver injury following hepatic ischemia/reperfusion in the rat , 2000, Hepatology.
[108] M. Dziejman,et al. IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1 , 2002, The Journal of Immunology.
[109] F. Chisari,et al. Blocking Chemokine Responsive to γ–2/Interferon (IFN)-γ Inducible Protein and Monokine Induced by IFN-γ Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus–specific Cytotoxic T Lymphocytes , 2001, The Journal of experimental medicine.
[110] S. Murakami,et al. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. , 1991, The Journal of biological chemistry.
[111] A. Gressner,et al. Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. , 1997, Gastroenterology.
[112] N. Sheron,et al. Chemokine levels in human liver homogenates: Associations between GRO α and histopathological evidence of alcoholic hepatitis , 1996, Hepatology.
[113] A. Bansal,et al. Serum levels of interleukins 8 and 10, interferon gamma, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis. , 1997, Autoimmunity.
[114] L. Toledo-Pereyra,et al. P-selectin and chemokine response after liver ischemia and reperfusion. , 2000, Journal of the American College of Surgeons.
[115] S. Milani,et al. Expression of the thrombin receptor in human liver: Up‐regulation during acute and chronic injury , 1998, Hepatology.
[116] N. Copeland,et al. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[117] D. Adams,et al. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. , 2001, Transplantation.
[118] A. Gressner,et al. Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells. , 1999, Journal of hepatology.
[119] C. Biron,et al. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. , 2000, The Journal of clinical investigation.
[120] C. Chitnis,et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.